Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on: March 07,2024

Structural analysis of relevant drug targets for Alzheimer's disease

by Bentham Science PublishersAlzheimer's Disease (AD) is classified as a neurodegenerative non-curable disease that affects millions worldwide. Current drugs have side effects that are significant

Updated on:March 07,2024

Sleep loss rewires the brain for cravings and weight gain. A neurologist explains the science behind the cycle

Updated on: July 04,2025

Sleep loss rewires the brain for cravings and weight gain. A neurologist explains the science behind the cycle

Updated on:July 04,2025

Optogenetics approach reveals how alcohol use disorder impairs cognitive flexibility

by Danielle Michaud,Texas A&M UniversityExcessive alcohol intake reduces thalamically evoked burst-pause response in DMS CINs and impairs reversal of operant conditioning. Credit:Scien

Updated on: January 15,2025

Optogenetics approach reveals how alcohol use disorder impairs cognitive flexibility

by Danielle Michaud,Texas A&M UniversityExcessive alcohol intake reduces thalamically evoked burst-pause response in DMS CINs and impairs reversal of operant conditioning. Credit:Scien

Updated on:January 15,2025

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.

Updated on: March 19,2024

AsEH enzyme: A new pharmacological target against Alzheimer's disease

by University of BarcelonaCredit: Unsplash/CC0 Public DomainA UB study published in the journalNeurotherapeuticshas validated a new pharmacological target for Alzheimer's disease.

Updated on:March 19,2024

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f

Updated on: April 16,2024

Alzheimer's: Blood biomarker may help identify the disease ten years before symptoms start

by Caroline Graff and Charlotte Johansson,The ConversationCredit: AI-generated imageThough Alzheimer's disease affects more than55 million people worldwide, there's still no cure f

Updated on:April 16,2024

A sense of touch: ASICs are the receptor for a proton synaptic messenger between Merkel cells and an afferent nerve

by Jeff Hansen,University of Alabama at BirminghamCredit:Neuron(2024). DOI: 10.1016/j.neuron.2024.01.018Transduction is the changing of one form of energy into another, such as a spo

Updated on: March 13,2024

A sense of touch: ASICs are the receptor for a proton synaptic messenger between Merkel cells and an afferent nerve

by Jeff Hansen,University of Alabama at BirminghamCredit:Neuron(2024). DOI: 10.1016/j.neuron.2024.01.018Transduction is the changing of one form of energy into another, such as a spo

Updated on:March 13,2024

Critical Analysis of CDKN2A Deletion's Role in Lipid Metabolism Remodeling and Ferroptosis Sensitivity in Glioblastoma Multiforme

Updated on: September 21,2024

Critical Analysis of CDKN2A Deletion's Role in Lipid Metabolism Remodeling and Ferroptosis Sensitivity in Glioblastoma Multiforme

Updated on:September 21,2024

The molecular mechanisms of Alzheimer's

by Pacific Northwest National LaboratoryFigure 1 in the paper outlines the quantitative proteomic pipeline for O-GlcNAc analysis. stochastic kinetic simulations (red) and simulations using the co

Updated on: April 07,2024

The molecular mechanisms of Alzheimer's

by Pacific Northwest National LaboratoryFigure 1 in the paper outlines the quantitative proteomic pipeline for O-GlcNAc analysis. stochastic kinetic simulations (red) and simulations using the co

Updated on:April 07,2024

Understanding removal of brain fluid provides avenue for Alzheimer's treatment

by Alzheimer's Research UKResearchers in Switzerland have investigated the way fluid is removed from around the brain. Finding a new pathway for its removal, their work may signal a paradigm

Updated on: March 07,2024

Understanding removal of brain fluid provides avenue for Alzheimer's treatment

by Alzheimer's Research UKResearchers in Switzerland have investigated the way fluid is removed from around the brain. Finding a new pathway for its removal, their work may signal a paradigm

Updated on:March 07,2024

Genetic marker that often points to heart disease and Alzheimer's may have fertility benefit

by Arizona State UniversityBen Trumble inside ASU's lab at the School of Human Evolution and Social Change. Credit: Charlie Leight/ASU NewsPrevious research has revealed that the Apolipoprote

Updated on: July 01,2024

Genetic marker that often points to heart disease and Alzheimer's may have fertility benefit

by Arizona State UniversityBen Trumble inside ASU's lab at the School of Human Evolution and Social Change. Credit: Charlie Leight/ASU NewsPrevious research has revealed that the Apolipoprote

Updated on:July 01,2024

High rate of diabetes, high blood pressure in Puerto Ricans linked to brain changes

by American Academy of NeurologyCredit: CC0 Public DomainThe high rate of diabetes and high blood pressure combined in Puerto Rican people may be linked to structural changes in the brain, accord

Updated on: February 05,2024

High rate of diabetes, high blood pressure in Puerto Ricans linked to brain changes

by American Academy of NeurologyCredit: CC0 Public DomainThe high rate of diabetes and high blood pressure combined in Puerto Rican people may be linked to structural changes in the brain, accord

Updated on:February 05,2024

Alzheimer's: carriers of risk gene show brain changes in their 20s – here's why we shouldn't worry

by Mark Postans And Carl J Hodgetts,The ConversationCredit: AI-generated imageDramatic developments in genetics research and the availability of commercial genetics tests have put us in a very m

Updated on: April 20,2024

Alzheimer's: carriers of risk gene show brain changes in their 20s – here's why we shouldn't worry

by Mark Postans And Carl J Hodgetts,The ConversationCredit: AI-generated imageDramatic developments in genetics research and the availability of commercial genetics tests have put us in a very m

Updated on:April 20,2024